Toronto, ON, Canada
Unlock the potential of your clinical trials through a novel AI solution.
Effortlessly generate and decipher insights on treatment efficacy, toxicity, and placebo response
NetraMark combines proprietary QML/ML algorithms with cross-domain expertise to bring ML commercialization into reality, starting with the pharmaceutical space in drug development where we utilize large and small data in order to help pharmaceutical companies understand their patient populations better. Our technology allows for the utilization of phase II data in order to optimize phase III trials from the vantage of their specific patient population.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Netramark on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
